These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 38625948

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries.
    Yang Y, Konrad RJ, Ploug M, Young SG.
    J Lipid Res; 2024 Jul; 65(7):100578. PubMed ID: 38880127
    [Abstract] [Full Text] [Related]

  • 3. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.
    Balasubramaniam D, Schroeder O, Russell AM, Fitchett JR, Austin AK, Beyer TP, Chen YQ, Day JW, Ehsani M, Heng AR, Zhen EY, Davies J, Glaesner W, Jones BE, Siegel RW, Qian YW, Konrad RJ.
    J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397
    [Abstract] [Full Text] [Related]

  • 4. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.
    Chen YQ, Pottanat TG, Zhen EY, Siegel RW, Ehsani M, Qian YW, Konrad RJ.
    J Lipid Res; 2021 May; 62():100068. PubMed ID: 33762177
    [Abstract] [Full Text] [Related]

  • 5. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.
    Yang Y, Beigneux AP, Song W, Nguyen LP, Jung H, Tu Y, Weston TA, Tran CM, Xie K, Yu RG, Tran AP, Miyashita K, Nakajima K, Murakami M, Chen YQ, Zhen EY, Kim JR, Kim PH, Birrane G, Tontonoz P, Ploug M, Konrad RJ, Fong LG, Young SG.
    J Clin Invest; 2023 Dec 01; 133(23):. PubMed ID: 37824203
    [Abstract] [Full Text] [Related]

  • 6. A unified model for regulating lipoprotein lipase activity.
    Zhang R, Zhang K.
    Trends Endocrinol Metab; 2024 Jun 01; 35(6):490-504. PubMed ID: 38521668
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
    Chi X, Britt EC, Shows HW, Hjelmaas AJ, Shetty SK, Cushing EM, Li W, Dou A, Zhang R, Davies BSJ.
    Mol Metab; 2017 Oct 01; 6(10):1137-1149. PubMed ID: 29031715
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity.
    Wen Y, Chen YQ, Konrad RJ.
    Adv Biol (Weinh); 2022 Oct 01; 6(10):e2200093. PubMed ID: 35676229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
    Lin CY, Chen PY, Hsu HJ, Gao WY, Wu MJ, Yen JH.
    Int J Mol Sci; 2022 Oct 18; 23(20):. PubMed ID: 36293338
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
    Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J.
    J Biol Chem; 2005 Jun 03; 280(22):21553-60. PubMed ID: 15774484
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.